rare diseases

settlement

Pharma

Catalyst's Teva settlement postpones arrival of Firdapse generic

Thanks to a new settlement with Catalyst, Teva is barred from marketing its Firdapse generic in the U.S. until Feb. 25, 2035, at the earliest.

Fraiser Kansteiner Jan 9, 2025 10:08am

green light go go ahead advance yes streetlight

FDA approves Neurocrine's Crenessity for genetic adrenal disease

Dec 16, 2024 11:26am

Novo Nordisk Odense Denmark production facility manufacturing plant

Novo Nordisk to build $1.2B rare disease drug factory in Denmark

Dec 16, 2024 10:26am

psych neuro brain

PTC wins FDA approval for brain-delivered gene therapy Kebilidi

Nov 14, 2024 11:31am

Image of a neon sign with the word no lit up next to an unlit yes

FDA shoots down Intercept's bid for full approval of Ocaliva

Nov 12, 2024 2:12pm

A small plant growing in a crack in the ground with a shadow of a tree behind it

Biologics gaining ground in HS, but more support needed: Spherix

Nov 11, 2024 11:52am